Bioresorbable Polymer Drug Eluting Stents

ABC

Editorial

Bioresorbable Polymer Drug-Eluting Stents: A Solid Presence in Cath-Labs, but Enough?

Monica Verdoia et al. Maria Antonieta Albanez Andrea Rognoni

Several generations of drug-eluting stents (DES) have followed, trying to reduce the invasiveness of metal struts and device-related complications. Yet, despite the achievement of very low rates of stent thrombosis (<1%) and restenosis (<5%), these events still impact the outcomes of patients with coronary artery disease, especially in more complex anatomical or clinical subsets.^,

The progressive reduction of metal strut thickness, with the development of new materials and stent design, has allowed to improve trackability and prevented the excessive caging of the vessel, being more respectful of vasomotion and side branches. In addition, diminishing the traumatic and inflammatory stimulus with thinner struts could account for fewer restenotic events.

[…]

Bioresorbable Polymer Drug Eluting Stents
Clinical Outcomes
restenosis

Read Full Article

Bioresorbable Polymer Drug-Eluting Stents: A Solid Presence in Cath-Labs, but Enough?

Electronic Document Format (Vancouver)

Electronic Document Format (ABNT)

Electronic Document Format (APA)

Electronic Document Format (ISO)